Company Filing History:
Years Active: 2015
Title: Rick Coulon: Innovator in Topical Estrogen Formulations
Introduction
Rick Coulon is a notable inventor based in Cummings, GA (US). He has made significant contributions to the field of medical formulations, particularly in the treatment of dry eye syndrome. His innovative approach focuses on the use of estrogen and its analogs for therapeutic applications.
Latest Patents
Rick Coulon holds a patent for "Time-release and micro-dose formulations for topical application of estrogen and estrogen analogs or other estrogen receptor modulators in the treatment of dry eye syndrome, and methods of preparation and application." This patent describes a topical application formulation designed to treat primary or secondary dry eye syndrome, also known as keratoconjunctivitis sicca (KCS). The preferred formulations include 17-β-estradiol and its derivatives, which are delivered in lipid, liposomes, polymers, or aqueous and non-aqueous vehicles. These formulations are particularly effective for the ocular surface tissues and can be utilized as time-release or micro-dose applications. Additionally, they may be beneficial for patients experiencing KCS due to post-operative refractive surgery or corneal transplants.
Career Highlights
Rick Coulon is associated with Altos Vision Limited, where he continues to develop innovative solutions in the field of ophthalmology. His work has garnered attention for its potential to improve the quality of life for individuals suffering from dry eye syndrome.
Collaborations
Rick has collaborated with esteemed colleagues, including Clive H Reading and Thomas L Rowe, to advance research and development in his field. Their combined expertise contributes to the innovative projects at Altos Vision Limited.
Conclusion
Rick Coulon's contributions to the field of topical estrogen formulations represent a significant advancement in the treatment of dry eye syndrome. His innovative patent and ongoing work at Altos Vision Limited highlight his commitment to improving patient care through scientific innovation.